Table 1.
Patient |
Age (y) |
Sex |
Stage |
Primary dose (Gy) |
Elective intermediate dose (Gy) |
Elective low dose (Gy) |
No. of fractions |
PTV V95 IMPT (%) |
PTV V95 VMAT (%) |
1 | 76 | M | T2N0 | 50.4 | 45 | 28 | 99.96 | 99.14 | |
2 | 48 | F | T3N3 | 54 | 50.4 | 45 | 30 | 95.26 | 91.95 |
3 | 84 | F | T3N2 | 54 | 50.4 | 45 | 30 | 97.97 | 98.59 |
4 | 62 | M | T2N0 | 50.4 | 42 | 28 | 99.58 | 99.01 | |
5 | 50 | F | T3N0 | 54 | 45 | 30 | 100 | 100 | |
6 | 57 | M | T4N1 | 54 | 45 | 30 | 99.45 | 98.24 | |
7 | 56 | M | T3N2 | 54 | 50.4 | 45 | 30 | 99.6 | 97.29 |
8 | 60 | F | T3N1 | 54 | 50.4 | 45 | 30 | 100 | 99.24 |
9 | 70 | F | T2N0 | 50.4 | 42 | 28 | 100 | 99.53 |
Abbreviations: PTV, planning target volume; IMPT, intensity-modulated proton therapy; VMAT, volumetric arc therapy; M, male; F, female.